AVIVAGEN (VIVXF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 20 247 sessions, September 18, 2023 to September 18, 2024
- Largest daily move
- +925% close of December 26, 2023
- 1-year change
- -97.8% closing prices, September 18, 2023 to September 18, 2024
- 1-month change
- -97.2% closing prices, August 16, 2024 to September 18, 2024
Company Description
AVIVAGEN (OTC: VIVXF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $7.8K.
VIVXF has declined 97.8% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for VIVXF, including price data, latest news, and short interest trends.
Stock Performance
AVIVAGEN (VIVXF) closed at $0.0001 on September 18, 2024. Over the past 12 months, the price has lost 97.8%.
VIVXF Metrics & Rankings
Price returns through September 18, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
AVIVAGEN has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all VIVXF news →
SEC Filings
Short Interest History
Short interest in AVIVAGEN (VIVXF) currently stands at 1.9 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for AVIVAGEN (VIVXF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 105.6 to 1000.0 days.
VIVXF Company Profile & Sector Positioning
AVIVAGEN (VIVXF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing VIVXF often look at related companies in the same sector, including BLOOMIOS INC (BLMS), ONASSIS HOLDINGS CORP (ONSS), ITEM 9 LABS CORP (INLB), EMERGENT HEALTH CORP (EMGE), and HALO COLLECTIVE INC (HCANF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VIVXF's relative position within its industry.